What is the prevalence of Larsen syndrome?

Larsen syndrome is a rare genetic skeletal disorder with an estimated prevalence of approximately 1 in 100,000 live births worldwide. Because the condition is often underdiagnosed or misdiagnosed due to its broad spectrum of clinical severity, these figures are considered estimates rather than precise epidemiological counts.

Is Larsen syndrome considered a common or rare disease?

Larsen syndrome is classified as a rare disease. It is a congenital disorder characterized by multiple joint dislocations, typical craniofacial features, and skeletal abnormalities. Because it is rare, many clinicians may not encounter a patient with Larsen syndrome during their entire practice, which contributes to the difficulty in establishing exact global prevalence statistics. The condition remains a subject of ongoing clinical research to better understand its true frequency across diverse populations.

How does the prevalence of Larsen syndrome vary by demographics?

Current medical literature does not suggest a significant difference in prevalence between males and females; Larsen syndrome affects both genders equally. Regarding age of onset, it is strictly a congenital condition, meaning individuals are born with the physical manifestations. While the skeletal anomalies are present at birth, the severity can vary significantly, sometimes leading to a delayed diagnosis if the symptoms are mild. There is no definitive evidence of specific geographic or ethnic clusters for Larsen syndrome, though it has been identified in populations worldwide.

Why is accurate data on Larsen syndrome difficult to obtain?

Accurate epidemiological data for Larsen syndrome is hindered by several factors:

• Clinical Heterogeneity: The range of symptoms is vast, from mild joint laxity to severe orthopedic deformities, leading to potential misdiagnosis.


• Underdiagnosis: Milder cases may go unrecognized or be misattributed to other connective tissue disorders.


• Genetic Complexity: Mutations in the FLNB gene are primarily responsible, but the variable expressivity makes identification challenging for healthcare providers who are not specialists in skeletal dysplasias.

What does the DiseaseMaps community tell us about this condition?

While formal clinical databases provide the baseline, real-world data offers a different perspective. At DiseaseMaps.org, 58 people with Larsen syndrome have joined the community and shared their experiences. This data helps bridge the gap between clinical textbooks and the lived reality of patients, highlighting the importance of patient-led registries in tracking rare conditions where centralized government data may be sparse.

Next steps

• Consult a medical geneticist or a pediatric orthopedic specialist to discuss your or your child's specific symptoms.


• Request a referral for genetic testing, specifically for mutations in the FLNB gene, to confirm a diagnosis of Larsen syndrome.


• Join the DiseaseMaps.org community to connect with other families and share experiences regarding management and care.


• Monitor updates from the NIH GARD website for the most recent clinical trial information and support resources.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.

References

• Orphanet: Larsen syndrome (ORPHA:494)


• NIH Genetic and Rare Diseases Information Center (GARD): Larsen syndrome overview


• OMIM (Online Mendelian Inheritance in Man): #150250 (Larsen syndrome)


• PubMed: Clinical and genetic spectrum of FLNB-related disorders